Home/Filings/4/0001181431-14-037954
4//SEC Filing

ACHILLION PHARMACEUTICALS INC 4

Accession 0001181431-14-037954

CIK 0001070336operating

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 5:05 PM ET

Size

5.2 KB

Accession

0001181431-14-037954

Insider Transaction Report

Form 4
Period: 2014-12-02
Apelian David
EVP and Chief Medical Officer
Transactions
  • Award

    Employee Stock Option(Right to Buy)

    2014-12-02175,000175,000 total
    Exercise: $13.24Exp: 2024-12-02Common Stock (175,000 underlying)
Footnotes (1)
  • [F1]This option grant vests as to 25% of the shares on the first anniversary of the date of grant and as to an additional 6.25% at the end of each three month period thereafter.

Issuer

ACHILLION PHARMACEUTICALS INC

CIK 0001070336

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070336

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 5:05 PM ET
Size
5.2 KB